• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • Opinion
    • Global health

    Opinion: Protecting hard-won global health gains in a 'post-aid' world

    New research by the Center for Global Development unveils major problems with how self-procuring middle-income countries buy and access lifesaving health products. Janeen Madan Keller and Kalipso Chalkidou explain and chart a path forward.

    By Janeen Madan Keller, Kalipso Chalkidou // 17 June 2019
    A nurse holds a syringe as a patient waits in Ghana. Photo by: Gavi /2019 /Tony Noel via REUTERS

    Transitioning away from donor aid is global development good news. Countries are growing wealthier and increasingly self-sufficient. But within this broader success story, withdrawal of donor support for procuring high-quality medicines, diagnostics, and devices threatens to leave middle-income countries in the lurch.

    Together, the efforts of bilateral and multilateral global health organizations have rapidly expanded access to cost-effective health technologies around the world. With aid transition, procurement of those lifesaving products is moving rapidly from the global to national or subnational levels — and, in the process, threatening the global health community’s capacity to ensure a reliable and affordable supply of high-quality essential medicines and other health products in the coming years. In a new Center for Global Development report, we found several serious problems with how self-procuring middle-income countries buy and access lifesaving health products.

    First, country purchasers may face high — and highly variable — prices. Global health institutions, such as the Global Fund and Gavi, aggregate demand across multiple countries through institutional negotiations. Pooling purchases at the global level helps lower drug prices by minimizing transaction costs, ensuring greater reliability for suppliers, and building negotiating power.

    But as countries become ineligible for donor support, more fragmentation could result in higher prices. For example, self-procuring middle-income countries pay between $10 and $50 for a single dose of pneumococcal conjugate vaccine, compared to the Gavi-negotiated price of roughly $3. Faced with these high prices, countries such as Thailand have found that the vaccine would not be locally cost-effective — and have decided against its introduction.

    Second, as development assistance for health wanes, middle-income governments can be slow to fill the resulting financing gap. Without robust public financing of essential medicines, many patients turn to the private sector. Donors account for half of all spending on health products in low-income countries, but in lower-middle-income countries, 80 percent of health products are procured through the private sector, where most households pay out of pocket. This “missing middle” problem — observed both in our work and IHME’s analysis of global health financing trends — could undermine progress toward universal health coverage.

    Third, as countries move toward self-procurement, medicines of unknown or poor quality may enter the supply chain. In collaboration with the World Health Organization’s prequalification program, global health funders have helped ensure consistent quality for many donor-purchased health products. In the absence of robust quality control systems — a frequent problem in low- and middle-income countries — purchasers may be unable to ensure quality and safety. For example, the Global Drug Facility found that 29 low- and middle-income countries purchased tuberculosis medicines of unknown quality between 2016 and 2018.

    If we want to ensure universal access to lifesaving health products, the transition from current global health mechanisms — the so-called “end of aid”— cannot be the end of global health cooperation. Instead, global health institutions must sustain, and possibly expand, global cooperation for procurement with an evolving toolkit tailored to the changing context.

    At the global and regional levels, new and expanded pooled procurement mechanisms can help counter the perverse effects of fragmentation, while donor support for information-sharing, market intelligence, and e-platforms can equip public purchasers with greater visibility into product quality and pricing. Finally, even after countries have transitioned from external aid, donors should consider continued subsidies for specific products that have important positive externalities or that are marginally cost-effective.

    By reimagining global cooperation for procurement, we can protect hard-won gains and accelerate progress in global health — even in a “post-aid” world.

    More reading

    ► Tech solutions to fight fake medicines 

    ► Bringing the medicine access fight to the US

    ► Health tech solutions for low-resource areas emerge from MIT Solve

    • Global Health
    • Center for Global Development
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
    The views in this opinion piece do not necessarily reflect Devex's editorial views.

    About the authors

    • Janeen Madan Keller

      Janeen Madan Keller

      Janeen Madan Keller is a senior policy analyst and assistant director of global health at the Center for Global Development. Since joining CGD in June 2015, her research has covered a range of topics including global health financing and aid effectiveness, among others. Previously, she spent two years in Dakar, Senegal, where she worked with the U.N. World Food Programme supporting nutrition and food security programs across West Africa.
    • Kalipso Chalkidou

      Kalipso Chalkidou

      Kalipso Chalkidou is the director of the department of health financing and economics at the World Health Organization. Before that, she founded and led the department of health finance at the Global Fund to Fight AIDS, Tuberculosis and Malaria. She is a visiting professor of global health at Imperial College London’s School of Public Health. Before moving to Geneva, she was director of global health policy and a senior fellow at the Center for Global Development.

    Search for articles

    Related Stories

    Global healthNew partnerships aim to fix Africa's broken medical supply chains

    New partnerships aim to fix Africa's broken medical supply chains

    Global HealthOpinion: How we must rethink the future of women’s and children’s health

    Opinion: How we must rethink the future of women’s and children’s health

    Global HealthOpinion: Ensuring oxygen access is essential to achieving health for all

    Opinion: Ensuring oxygen access is essential to achieving health for all

    Global Health ‘What’s in’ and ‘what’s out’ in USAID’s global health programming

    ‘What’s in’ and ‘what’s out’ in USAID’s global health programming

    Most Read

    • 1
      The power of diagnostics to improve mental health
    • 2
      Lasting nutrition and food security needs new funding — and new systems
    • 3
      Opinion: Urgent action is needed to close the mobile gender gap
    • 4
      Supporting community-driven solutions to address breast cancer
    • 5
      The top local employers in Europe
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement